Jintropin AQ 30 IU is a synthetic human growth hormone (HGH) used for the treatment of growth hormone deficiency in adults and children. It is an anabolic agent that promotes the growth and development of muscle tissue, bone density, and other body tissues. Jintropin AQ 30 IU is manufactured by GeneScience Pharmaceuticals Co. Ltd. and is widely available in many countries.
Composition:
Jintropin AQ 30 IU contains somatropin, a synthetic form of human growth hormone (HGH) that is identical to the naturally occurring hormone in the body. Each kit of Jintropin AQ 30 IU contains one vial of 30 IU somatropin in a liquid form and one ampoule of sterile water for injection. The drug also contains other excipients like disodium phosphate, mannitol, and glycine.
Uses:
Jintropin AQ 30 IU is used for the treatment of growth hormone deficiency in adults and children. In children, it is used to treat growth failure due to various medical conditions like Turner syndrome, Prader-Willi syndrome, chronic kidney disease, and idiopathic short stature. In adults, Jintropin AQ is used to treat the symptoms of growth hormone deficiency, including decreased muscle mass, increased body fat, decreased bone density, and decreased energy levels.
Usage and Dosage:
Jintropin AQ 30 IU is administered via subcutaneous injection. The dosage and duration of treatment depend on the individual’s condition and their response to the treatment. The recommended starting dose for children is 0.1 IU/kg/day, and for adults, it is 0.2-0.3 IU/kg/day. The drug is usually administered once daily before bedtime. It is important to follow the dosage instructions provided by the healthcare provider.
Storage Conditions:
Jintropin AQ 30 IU should be stored in a cool, dry place, away from direct sunlight and moisture. The drug should be kept in the refrigerator between 2-8°C. Once reconstituted with sterile water for injection, the drug should be used immediately or stored in a refrigerator for up to 7 days. Do not freeze or shake the vial. The drug should be kept out of reach of children and pets.
Mechanism of Action:
Jintropin AQ works by stimulating the growth of cells and tissues in the body. It binds to specific receptors in the body and initiates a signal cascade that leads to the production of insulin-like growth factor 1 (IGF-1). IGF-1 promotes cell proliferation, differentiation, and growth of skeletal muscle, bone, and other tissues.
Contraindications:
Jintropin AQ is contraindicated in individuals with active malignancy, hypersensitivity to any of the drug components, severe respiratory impairment, acute illness, or open epiphyses. It should also be avoided in pregnant and breastfeeding women, as well as individuals with diabetes, severe obesity, or a history of intracranial hypertension.
Interactions:
Jintropin AQ may interact with certain medications, including corticosteroids, antidiabetic drugs, and somatostatin analogs. These medications may interfere with the effectiveness of Jintropin AQ. Therefore, it is important to inform the healthcare provider of any medications or supplements being taken before starting Jintropin AQ.
Side Effects:
Common side effects of Jintropin AQ include injection site reactions, flu-like symptoms, joint pain, edema, and carpal tunnel syndrome. In rare cases, it may also cause allergic reactions, increased intracranial pressure, or acromegaly. If any side effects are experienced, it is important to inform the healthcare provider immediately.
Reviews
There are no reviews yet.